Cross-talk between endothelial cells and tumor via delta-like ligand4/Notch/PTEN signaling inhibits lung cancer growth

Oncogene

Volumn 31, Issue 23, 2012, Pages 2899-2906

  Ding, X Y ^a   Ding, J ^b   Wu, K ^b   Wen, W ^b   Liu, C ^b   Yan, H X ^b   Chen, C ^b   Wang, S ^a   Tang, H ^a   Gao, C K ^a   Guo, L N ^b   Cao, D ^b   Li, Z ^b   Feng, G S ^a   Wang, H Y ^b   Xu, Z F ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

delta like ligand 4; lung cancer; Notch; PTEN; vascular endothelial cells

Indexed keywords

DELTA LIKE LIGAND 4; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RECOMBINANT PROTEIN; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; MICE, NUDE; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

MUS MUSCULUS;

EID: 84861974104     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.467     Document Type: Article

References (37)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ. (1999). Notch signaling: cell fate control and signal integration in development. Science 284: 770-776. (Pubitemid 29291335)
2. Benedito R, Roca C, Sorensen I, Adams S, Gossler A, Fruttiger M et al. (2009). The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137: 1124-1135.
3. Chen Y, De Marco MA, Graziani I, Gazdar AF, Strack PR, Miele L et al. (2007). Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res 67: 7954-7959. (Pubitemid 47395124)
4. Collins BJ, Kleeberger W, Ball DW. (2004). Notch in lung development and lung cancer. Semin Cancer Biol 14: 357-364. (Pubitemid 38993637)
5. Deftos ML, Bevan MJ. (2000). Notch signaling in T cell development. Curr Opin Immunol 12: 166-172. (Pubitemid 30133104)
6. Detterbeck FC, Boffa DJ, Tanoue LT. (2009). The new lung cancer staging system. Chest 136: 260-271.
7. Folkman J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
8. Fortini ME. (2009). Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 16: 633-647.
9. Graziani I, Eliasz S, De Marco MA, Chen Y, Pass HI, De May RM et al. (2008). Opposite effects of Notch-1 and Notch-2 on mesothelioma cell survival under hypoxia are exerted through the Akt pathway. Cancer Res 68: 9678-9685.
10. Haruki N, Kawaguchi KS, Eichenberger S, Massion PP, Olson S, Gonzalez A et al. (2005). Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res 65: 3555-3561. (Pubitemid 40616330)
11. Hofmann JJ, Luisa Iruela-ArispeM. (2007). Notch expression patterns in the retina: an eye on receptor-ligand distribution during angiogenesis. Gene Expr Patterns 7: 461-470. (Pubitemid 46177950)
12. Indraccolo S, Minuzzo S, Masiero M, Pusceddu I, Persano L, Moserle L et al. (2009). Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy. Cancer Res 69: 1314-1323.
13. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. (2008).Cancer Statistics, 2008. CA Cancer J Clin 58: 71-96.
14. Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP et al. (2007). Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res 67: 8051-8057. (Pubitemid 47395139)
15. Kunnimalaiyaan M, Traeger K, Chen H. (2005). Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol 289: G636-G642. (Pubitemid 41377169)
16. Kunnimalaiyaan M, Chen H. (2007). Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Oncologist 12: 535-542. (Pubitemid 350012116)
17. Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M et al. (2007). Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 67: 11244-11253. (Pubitemid 350248550)
18. Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD et al. (2007). Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 104: 3219-3224. (Pubitemid 46364140)
19. Mailhos C,Modlich U, Lewis J, Harris A, Bicknell R, Ish-Horowicz D. (2001). Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 69: 135-144. (Pubitemid 33755062)
20. Meurette O, Stylianou S, Rock R, Collu GM, Gilmore AP, Brennan K. (2009). Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res 69: 5015-5022.
21. Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW et al. (2006). Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444: 1032-1037. (Pubitemid 46018516)
22. Nor JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM et al. (2001). Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 61: 2183-2188. (Pubitemid 32692045)
23. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, CiofaniMet al. (2007). Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13: 1203-1210. (Pubitemid 47530629)
24. Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL. (2005). Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 65: 8690-8697. (Pubitemid 41377356)
25. Phng LK, Gerhardt H. (2009). Angiogenesis: a team effort coordinated by notch. Dev Cell 16: 196-208.
26. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y et al. (2006). Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444: 1083-1087. (Pubitemid 46018529)
27. Salmena L, Carracedo A, Pandolfi PP. (2008). Tenets of PTEN tumor suppression. Cell 133: 403-414. (Pubitemid 351622014)
28. Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R et al. (2007). Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood 109: 4753-4760. (Pubitemid 46827768)
29. Segarra M, Williams CK, Sierra Mde L, Bernardo M, McCormick PJ, Maric D et al. (2008). Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. Blood 112: 1904-1911.
30. Wen W, Ding J, Sun W, Wu K, Ning B, Gong W et al. (2010). Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells. Cancer Res 70: 2010-2019.
31. Whelan JT, Forbes SL, Bertrand FE. (2007). CBF-1 (RBP-J kappa) binds to the PTEN promoter and regulates PTEN gene expression. Cell Cycle 6: 80-84. (Pubitemid 46173885)
32. Williams CK, Li JL, Murga M, Harris AL, Tosato G. (2006). Up-regulation of the Notch ligand Delta-like 4 inhibits VEGFinduced endothelial cell function. Blood 107: 931-939. (Pubitemid 43156289)
33. Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L et al. (2009). Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening-a report from the American Society of Clinical Oncology. J Clin Oncol 27: 812-826.
34. Yan M, Plowman GD. (2007). Delta-like 4/Notch signaling and its therapeutic implications. Clin Cancer Res 13: 7243-7246.
35. Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, Ridgway JB et al. (2010). Chronic DLL4 blockade induces vascular neoplasms. Nature 463: E6-E7.
36. Yin Y, Shen WH. (2008). PTEN: a new guardian of the genome. Oncogene 27: 5443-5453.
37. Zeng Q, Li S, Chepeha DB, Giordano TJ, Li J, Zhang H et al. (2005). Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8: 13-23. (Pubitemid 40991811)